Aprea Therapeutics, Inc.
APRE· Nasdaq
Aprea Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -6.79%
- Market cap
- $8.75M
- 12.59M shares
- Filings
- 444
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $7,043,035 | reported | |
| FY 2024 | 2024-12-31 | $9,363,537 | reported | |
| FY 2023 | 2023-12-31 | $7,627,491 | reported | |
| FY 2022 | 2022-12-31 | $16,402,273 | reported | |
| FY 2021 | 2021-12-31 | $23,895,875 | reported | |
| FY 2020 | 2020-12-31 | $37,879,325 | reported | |
| FY 2019 | 2019-12-31 | $20,950,672 | reported | |
| FY 2018 | 2018-12-31 | $14,194,732 | reported | |
| FY 2017 | 2017-12-31 | $13,392,631 | reported |
Aprea Therapeutics, Inc. · CIK 1781983 · Engraved from SEC EDGAR
